SCHEMBL6466099

SCHEMBL6466099

NC(=O)CC[C@H](CCc1ccccc1)C(O)c1nc2cc([N+](=O)[O-])ccc2o1

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
DAGLA Q9Y4D2 2/20 0.53
RAB9A P51151 7/20 0.44
NPC1 O15118 6/20 0.44
SMN1; SMN2 Q16637 4/20 0.44
MEN1 O00255 4/20 0.43
KMT2A Q03164 4/20 0.43
ALDH1A1 P00352 2/20 0.43
MAPT P10636 4/20 0.41
MCL1 Q07820 1/20 0.41
ATM Q13315 1/20 0.41
POLB P06746 2/20 0.40
PKM P14618 2/20 0.38
CYP1A2 P05177 2/20 0.37
CYP3A4 P08684 2/20 0.37
CYP2C9 P11712 2/20 0.37
CYP2C19 P33261 2/20 0.37
CYP24A1 Q07973 1/20 0.37
ASAH1 Q13510 1/20 0.37
LMNA P02545 1/20 0.36
KDM4E B2RXH2 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6463980 0.82 PIM1 (0.38) DAGLARAB9ANPC1SMN1; SMN2MAPT
SCHEMBL6467269 0.80 DAGLA (0.61) DAGLARAB9ANPC1SMN1; SMN2MEN1
SCHEMBL8060536 0.78 RAB9A (0.51) DAGLARAB9ANPC1SMN1; SMN2MEN1
SCHEMBL7042906 0.74 DAGLA (0.46) DAGLARAB9ANPC1SMN1; SMN2MEN1
SCHEMBL6466103 0.73 DAGLA (0.56) DAGLARAB9ANPC1SMN1; SMN2MEN1
SCHEMBL8060617 0.71 ITGA4 (0.46) DAGLARAB9ANPC1SMN1; SMN2MEN1
SCHEMBL2247603 0.67 RAB9A (0.61) DAGLARAB9ANPC1SMN1; SMN2MEN1
SCHEMBL7858147 0.66 XDH (0.46) RAB9ANPC1SMN1; SMN2MEN1KMT2A
SCHEMBL7736136 0.66 XDH (0.46) RAB9ANPC1SMN1; SMN2MEN1KMT2A
SCHEMBL7732480 0.66 HSD17B10 (0.41) DAGLARAB9ANPC1SMN1; SMN2ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1516877-A1 Amine derivatives as protease inhibitors AXYS PHARMACEUTICALS, INC. (US) 2005-03-23 EP disclosed